Katabi Maha Insider Trades

Insider Trading History

Track insider trading activity for Katabi Maha. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $438k 14,000 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$297k 14,000 shares
$21.19
$31.27
Aerovate Therapeutics
Aerovate Therapeutics AVTE
10% owner
Holding Value $33.5k 12,500 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.27M 12,500 shares
$661.50
$2.68
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $438k 14,000 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 14,000 shares
$42.69
$31.27
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $87.4M 2,793,987 shares
Last Trade
Mar 25, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.8M 340,000 shares
$40.50
$31.27
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $98M 3,133,987 shares
Last Trade
Mar 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.7M 413,450 shares
$40.51
$31.27
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $112M 3,595,690 shares
Last Trade
Mar 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.58M 81,009 shares
$44.20
$31.27
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $113M 3,628,446 shares
Last Trade
Jan 30, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.57M 161,290 shares
$34.51
$31.27
Aerovate Therapeutics
Aerovate Therapeutics AVTE
10% owner
Holding Value $9.43k 3,519 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.69M 3,519 shares
$763.35
$2.68
RayzeBio
RayzeBio RYZB
Director
Holding Value $1.14M 18,235 shares
Last Trade
Nov 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$414k 18,235 shares
$22.72
$62.49
Aerovate Therapeutics
Aerovate Therapeutics AVTE
10% owner
Holding Value $33.5k 12,500 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.13M 12,500 shares
$570.50
$2.68
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $625k 20,000 shares
Last Trade
May 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$154k 20,000 shares
$7.70
$31.27
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $7.04k 2,627 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.49M 2,627 shares
$946.05
$2.68
CinCor Pharma
CinCor Pharma CINC
Director
Holding Value $177M 6,073,949 shares
Last Trade
Aug 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.2M 500,000 shares
$34.31
$29.06
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $33.5k 12,500 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.36M 12,500 shares
$429.10
$2.68
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $310k 9,925 shares
Last Trade
May 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 9,925 shares
$16.14
$31.27
Aerovate Therapeutics
Aerovate Therapeutics AVTE
10% owner
Holding Value $19.4k 7,240 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.77M 7,240 shares
$382.55
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
10% owner
Holding Value $9.12M 3,401,544 shares
Last Trade
Jul 02, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.37B 3,401,544 shares
$697.90
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
10% owner
Holding Value $0 0 shares
Last Trade
Jul 02, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.37B 10,565,238 shares
$697.90
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
10% owner
Holding Value $10.1M 3,758,686 shares
Last Trade
Jul 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$249M 357,142 shares
$697.90
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
10% owner
Holding Value $6.61k 2,467 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.68M 2,467 shares
$679.35
$2.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up